仙琚制药(002332.SZ)：倍他米松磷酸钠注射液获批准注册

Core Viewpoint - The company, Xianju Pharmaceutical, has received approval from the National Medical Products Administration for the registration of Betamethasone Sodium Phosphate Injection, which is primarily used for diseases requiring glucocorticoid treatment [1] Group 1 - The company has announced the approval of Betamethasone Sodium Phosphate Injection [1] - The injection is indicated for conditions that necessitate glucocorticoid therapy [1]